Colton Thomas
Charged Alpha Stock Encyclopedia
Charged Alpha reviews earnings for each stock in the Russel 1000 every quarter. Each podcast gives thorough analysis, along with an in-depth profile in the beginning of the episode of the company, what they do, how they earn money and what to look for.
Husk å besøke podkastens nettsted og støtte skaperen: chargedalpha.podbean.com
Forfatter
Colton Thomas
Kategori
Podkastens nettsted
Siste episode
28. okt 2026
Hvor kan du lytte?
Podkaster i appen Replaio Radio Kommer snartPodkaster kommer snart til appen. Installer nå, og bli den første som ser en helt ny tilnærming til podkaster
Episoder
Twist Bioscience (TWST): Revenue +23% And The Loss Got BIGGER. Is TWST a Buy? 03.08.2026 14:16
Twist Bioscience Corporation (TWST) Q3 FY2026 — Reported before the open (fiscal Q3 2026, the three months ended June 30, 2026). Revenue $118.4M, +23.2% — a ~$3.8M BEAT. Diluted loss per share $0.56 against a Street estimate near $0.50 — a 6-cent MISS. Adjusted EBITDA NEGATIVE $11.3M against NEGATIVE $8.0M — the loss WIDENED $3.3M. FY2026 revenue guidance RAISED to $456–457M from $442–447M. The st...
CNH Industrial (CNH): Profit Fell 35% And The Stock ROSE 8%. Is CNH a Buy? 03.08.2026 15:16
CNH Industrial N.V. (CNH) Q2 2026 — Reported before the open (three months ended June 30, 2026). Consolidated revenues $4,803M, +2% (FLAT at constant currency); Industrial net sales $4,143M, +3%. Net income $141M vs $217M — DOWN 35%. Diluted EPS $0.11 vs $0.17. Adjusted EPS $0.13 vs a ~$0.10 Street number — a 3-cent BEAT. FY guide narrowed UP to $0.41-$0.46. The stock rose anyway: from a $10.25 cl...
Krystal Biotech (KRYS): US Sales FELL On A 24% Beat. Is KRYS a Buy? 03.08.2026 14:12
Krystal Biotech, Inc. (KRYS) Q2 2026 — Reported before the open (three months ended June 30, 2026). Revenue $119.222M, +24.1%, just UNDER a ~$120.9M Street number. Diluted EPS $1.79 vs ~$1.70 — a BEAT. Operating income $58.417M at a 49.0% margin. The stock fell anyway: from a $341.12 close it opened at $320.70, hit $297.73, and sat at $299.04 — DOWN 12.3%. The framing nobody applied: the 10-Q's ge...
Tyson Foods (TSN): Chicken Is A Peak, Not A Base. Is TSN a Buy? 03.08.2026 12:44
Tyson Foods, Inc. (TSN) Q3 FY2026 — Reported before the open August 3, 2026 (fiscal Q3 FY2026, the thirteen weeks ended June 27, 2026). Adjusted EPS $0.99 (+9%) vs a ~$0.98 consensus. Adjusted operating income $547M (+8%) at a 3.9% margin. But sales were FLAT at $13,868M against a Street number nearer $14.07B — a miss — and gross margin fell to 6.6% from 8.2%. The stock opened at $55.89 (-3.6%), t...
Marriott (MAR): The Credit Card Did The Work. Is MAR a Buy? 03.08.2026 14:28
Marriott International, Inc. (MAR) Q2 2026 — Reported before the open August 3, 2026 (calendar Q2, quarter ended June 30). Adjusted diluted EPS $3.19 (+20.4%) vs a ~$3.08 consensus. Adjusted EBITDA $1,592M (+13%). But total revenues were $7,071M against a ~$7.19B Street number — a miss — and REPORTED operating income FELL 1% to $1,229M. The company raised full-year RevPAR growth to 3.0-3.5% and fu...
Carpenter Technology (CRS): Aerospace Was 120% Of The Growth. Is CRS a Buy? 03.08.2026 13:47
Carpenter Technology Corporation (CRS) Q4 FY2026 — Reported before the open July 30, 2026 (fiscal Q4 and fiscal year ended June 30). Net sales $851.0M (+12.6%), but +9.0% to $679.7M excluding the raw-material surcharge. Operating income a record $206.9M (+36.7%); diluted EPS $3.23 (+46.2%) vs a $3.09 consensus. SAO adjusted operating margin a record 37.8% vs 30.5% — an 18th consecutive quarter of...
DexCom (DXCM): Revenue Rose $151M And Cost Of Sales Rose $10M. Is DXCM a Buy? 03.08.2026 12:57
DexCom, Inc. (DXCM) Q2 2026 — Reported after the close July 30, 2026 (quarter ended June 30). Revenue $1,308.4M, +13.1% reported and +12% organic. US $933.4M (+11.0%); international $375.0M (+18.6%). GAAP operating margin 24.3% vs 18.4% — operating income +49.7%. GAAP diluted EPS $0.64 (+42%); non-GAAP $0.70 (+46%). Adjusted EBITDA $421.3M, 32.2% of revenue. FY26 revenue guidance raised at the mid...
Amphenol (APH): A Record Quarter Where Free Cash Flow Grew 7.5%. Is APH a Buy? 03.08.2026 14:16
Amphenol Corporation (APH) Q2 2026 — Reported before the open July 29, 2026 (quarter ended June 30). Net sales $8,758.1M, +55% in dollars and +30% ORGANIC. GAAP diluted EPS $1.37 (+59%); adjusted $1.35 (+67%). GAAP/adjusted operating margin 29.5%/29.8%, both records. Record orders of $10.7B for a 1.23:1 book-to-bill. Free cash flow $1,205.5M — up just 7.5%. Q3 guided to $9.3-9.4B and $1.40-1.42. T...
InterDigital (IDCC): A 5x Earnings Beat That Was Really A 13% Decline. Is IDCC a Buy? 03.08.2026 14:16
InterDigital, Inc. (IDCC) Q2 2026 — Reported before the open July 30, 2026 (quarter ended June 30). Revenue $260.2M crushed the company's own $139-143M outlook — but FELL 13.4% from $300.6M. Net income $116.4M vs $180.6M; GAAP EPS $3.40 vs $5.35; non-GAAP EPS $4.62 vs $6.52. Adj. EBITDA $184.1M (71%) vs $236.7M (79%). Opex +27.1%. ARR hit a record $625.7M (+13.1%); catch-up was $103.7M, 40% of the...
Qorvo (QRVO): Gross Margin Jumped 1,060bps — But 66% Of The Stock Is Now Skyworks. Is QRVO a Buy? 03.08.2026 13:09
Qorvo, Inc. (QRVO) Q1 FY2027 — Reported after the close July 28, 2026 (fiscal Q1 2027, quarter ended June 27; Qorvo's FY ends in early April). Revenue $784.8M (-4.2%) beat the ~$758M consensus. GAAP gross margin 51.1% vs 40.5% — up 1,060bps, a fifth straight quarter of expansion. GAAP operating income $96.8M vs $30.1M (+221.6%) on 4.2% LESS revenue. Non-GAAP diluted EPS $1.64 vs ~$1.10 expected an...
Quanta (PWR): +17% On A Record Quarter — But It Blew Past Its Own 2030 Plan. Is PWR a Buy? 03.08.2026 13:13
Quanta Services, Inc. (PWR) Q2 2026 — Reported July 30, 2026 pre-open. Revenue $9.557B (+41.1%) vs ~$8.61B expected — an 11% beat. Adjusted diluted EPS $4.24 vs $3.31 expected and $2.48 a year ago (+71%); GAAP EPS $2.96 vs $1.52. Adjusted EBITDA $1,066.5M (+59.5%), an 11.2% margin. Both segments expanded margin: Electric $7.84B (+43.6%) at 11.5% vs 10.1%, Underground $1.72B (+30.7%) at 9.1% vs 6.9...
Corcept (CORT): +27% On A Huge Beat — But The Guide Needs Lifyorli To Triple. Is CORT a Buy? 03.08.2026 14:37
Corcept Therapeutics Incorporated (CORT) Q2 2026 — Reported July 29, 2026 after the close for Q2 2026 (three months ended June 30). Revenue $256.1M (+31.7%) vs ~$220M expected, a 16% beat. Diluted EPS $0.36 vs $0.29 a year ago. Operating income $41.3M (+55%). Korlym and its authorized generic $208.6M (+7.3%); Lifyorli (relacorilant) $47.6M in its first quarter on the market, with 1,300+ patients s...
Garmin (GRMN): Record 62.4% Margin, Stock +12.6% — But H2 Is Guided To +7%. Is GRMN a Buy? 02.08.2026 13:47
Garmin Ltd. (GRMN) Q2 2026 — Reported July 29, 2026 pre-market for Q2 2026 (the 13 weeks ended June 27). Revenue $2,022M (+11.4%) vs ~$1.93B expected. Pro forma EPS $2.81 vs $2.30 expected, a $0.51 beat; GAAP EPS $2.80. Gross margin a record 62.4% (+360bps), operating margin 30.4% (+440bps), operating income $615.5M (+30%). Gross margin expanded in ALL FIVE segments. Full-year guidance RAISED to ~...
Eaton (ETN): Orders +41%, Backlog +43% — But GAAP EPS Fell 16%. Is ETN a Buy? 02.08.2026 13:28
Eaton Corporation plc (ETN) Q2 2026 — Reported July 31, 2026 pre-market for Q2 2026 (quarter ended June 30). Revenue $8,531M (+21%, organic +14%) vs ~$8.16B expected. Adjusted EPS $3.15 vs $3.07 expected, a Q2 record. GAAP diluted EPS $2.11 vs $2.51 — DOWN 16%. Segment margin 23.1%, above the high end of guidance but down 80bps YoY. Electrical Americas orders +41% (12-month rolling, organic); Elec...
Yum China (YUMC): EPS +21%, Revenue +13%, Margin Flat. Is YUMC a Buy? 02.08.2026 14:35
Yum China Holdings, Inc. (YUMC) Q2 2026 — Reported July 30 pre-market for Q2 2026 (quarter ended June 30). Total revenue $3,138M (+13% reported, +6% ex-F/X) vs ~$3.1B expected. Operating profit $348M (+14%), a Q2 record; core operating profit $328M (+7%). OP margin 11.1%, the 9th straight quarter of expansion. Diluted EPS $0.70 (+21%) vs ~$0.67 expected. Restaurant margin 16.1%, exactly FLAT. Same...
IES Holdings (IESC): Revenue +40%, Backlog +119%, Stock +30% in a Day. Is IESC a Buy? 02.08.2026 14:35
IES Holdings, Inc. (IESC) Q3 FY2026 — Reported July 31 for fiscal Q3 2026 (quarter ended June 30; IES's fiscal year ends Sept 30). Revenue $1,242.7M (+40%) vs ~$1,080M expected — a 15% beat. Operating income $178.5M (+60%), margin 14.4% vs 12.6%. Adjusted diluted EPS $6.70 vs $4.83 expected (+39%); GAAP diluted EPS $7.57 includes a $26.2M marketable-securities gain. Backlog $4.53B, +119% YoY. The...
Garrett Motion (GTX): Record Margin, Raised Guide — and the Stock Fell. Is GTX a Buy? 02.08.2026 14:35
Garrett Motion Inc. (GTX) Q2 2026 — Reported pre-market July 29 (calendar Q2 ended June 30, 2026). Net sales $976M (+7% reported, +5% cc) vs ~$963M expected; diluted EPS $0.53 vs ~$0.46 (+26%); adjusted EBIT margin a record 15.6%, up 200bps; FY26 guidance RAISED on every line. The stock fell 3.81% to $28.78 on the print, then rose 7.75% the next session to close the week at $31.15. The line nobody...
Mettler-Toledo (MTD): Beat, Raised — and 68% of the Growth Is the Buyback. Is MTD a Buy? 02.08.2026 14:59
Mettler-Toledo International Inc. (MTD) Q2 2026 — Reported after the close on July 30 (calendar Q2 ended June 30, 2026). Net sales $1,027.3M (+4.5% reported, +6% local currency ex a one-time customer tariff refund, +4% organic); adjusted EPS $11.46 vs ~$10.79 expected (+14%); GAAP diluted EPS $11.55 — higher than the adjusted figure; FY26 guidance raised to $47.15-$47.50. The stock rose 2.59% to $...
Skyworks (SWKS): A Beat, a $2B Buyback, a Killed Dividend — and Free Cash Flow Went NEGATIVE 02.08.2026 13:13
Skyworks Solutions, Inc. (SWKS) Q3 FY2026 — Reported after the close July 28 (fiscal Q3 2026 ended July 3; Skyworks' FY ends October 2). Revenue $934.8M (-3.1% YoY) beat ~$920M; non-GAAP EPS $1.08 beat $1.01 but fell 18.8%; GAAP EPS $0.22 vs $0.70. The board KILLED the dividend and authorised a new $2.0B buyback. The stock fell 5.4% on the print and finished July 31 at $62.28. The line nobody prin...
Disc Medicine (IRON): FDA Said No — the Stock Went Back Anyway. Is IRON a Buy? 02.08.2026 14:00
Disc Medicine, Inc. (IRON) Q2 2026 — Reported before the open on July 30 (calendar Q2 ended June 30, 2026). There is no revenue line: R&D $46.9M (+1.3%), SG&A $18.1M (+20.2%), total operating expenses $65.1M, net loss $59.5M vs $55.2M, loss per share $(1.54) vs $(1.58) on 38.69M weighted shares. Cash, equivalents and marketable securities $717.7M, runway guided into 2029. The stock closed...
IQVIA (IQV): Best Bookings Since 2022, Stock +14% — and GAAP Profit Did Not Move. Is IQV a Buy? 02.08.2026 13:17
IQVIA Holdings Inc. (IQV) Q2 2026 — Reported before the open on July 28 (calendar Q2 ended June 30, 2026). Revenue $4,368M (+8.7% YoY, +8.5% cc); adjusted EPS $3.15 vs $3.03 expected (+12.1%); GAAP diluted EPS $1.53 vs $1.54; adjusted EBITDA $994M (+9.2%); R&D Solutions net new bookings $3.15B (+19%, 1.22x book-to-bill); FY26 guidance raised. The stock closed $213.22 on July 27, jumped 13.9% t...
Woodward (WWD): Record Margins, a Raised Guide — and a 14% Drop. Is WWD Stock a Buy? 02.08.2026 8:56
Woodward, Inc. (WWD) Q3 FY2026 — Reported at 4:00pm ET on July 29 (fiscal Q3 ended June 30, 2026). Net sales $1,109.7M (+21% YoY); adjusted EPS $2.52 vs $2.44 expected (+43%); GAAP EPS $2.40; gross margin 31.5% from 27.2%; record segment margins in both businesses; FY26 adjusted EPS guidance raised to $9.30-$9.50. The stock closed $385.42 on July 29, fell 7.6% to $356.28 on July 30, and closed $36...
Impinj (PI): A RECORD Quarter Built on a Once-a-Year Cheque — Is PI Stock a Buy? 02.08.2026 14:12
Impinj, Inc. (PI) Q2 2026 — Reported after the close on July 29 (quarter ended June 30, 2026). Revenue $108.4M (+11% YoY) vs a $103-106M guide; non-GAAP EPS $0.86 vs ~$0.80 (GAAP $0.39); adjusted EBITDA $30.7M; non-GAAP gross margin 60.9% — all records. The stock closed +5.9% at $147.49 on July 30, then $151.36 on July 31. The record is partly a calendar artifact: ~$17.0M of the $108.4M is the ann...
Sonos (SONO): It Beat on EVERY Line — the Stock Fell 18% — Is SONO Stock a Buy? 02.08.2026 13:47
Sonos, Inc. (SONO) Q3 FY2026 — Reported after the close July 29 (quarter ended June 27, 2026). Revenue $375.3M (+8.8%), non-GAAP EPS $0.27 vs ~$(0.02) expected, adjusted EBITDA $44.0M (+24%), GAAP gross margin 50.4% vs non-GAAP 45.5%. The stock had run 19% into the print to $17.52, then fell 17.6% to $14.43 and closed the week at $14.66. GAAP gross margin came in ABOVE non-GAAP — 50.4% vs 45.5% —...
Sanofi (SNY): Sales +18%, Guidance RAISED — the Stock FELL. Is SNY Stock a Buy? 02.08.2026 14:16
Sanofi (SNY) Q2 2026 — Reported before the European open on July 30 (quarter ended June 30, 2026). Q2 net sales EUR 11,597M, +17.8% at constant exchange rates and +16.0% reported. Business EPS EUR 2.09 per ORDINARY share, +33.3% CER. Business operating income EUR 3,291M at a 28.4% margin, up 380bps. Q2 free cash flow EUR 2,670M, +86.8%. And FY2026 guidance was RAISED to around +10% sales growth at...
Lignende podkaster
Replaio er ikke podkastutgiver; programnavn, omslag og lyd tilhører opphavspersonene og distribueres via offentlige RSS-feeder.